Latest
Alnylam Wins $25 Million Milestone as Regeneron’s Livsayis Secures FDA Approval Alnylam Pharmaceuticals (NASDAQ: ALNY) said Regeneron received FDA approval
Alnylam Pharmaceuticals (NASDAQ: ALNY) said Regeneron received FDA approval for Livsayis (cemdisiran) to treat adults with anti-AChR antibody-positive generalized myasthenia gravis, marking the first...
Block’s Square Partners With NAB to Expand Business Banking Integration in Australia Block (NYSE: XYZ) announced a partnership between Square
Block (NYSE: XYZ) announced a partnership between Square Australia and National Australia Bank aimed at simplifying payments and cash-flow management for Australian businesses. The...
Zoetis Wins USDA License for 3-in-1 Poultry Vaccine Zoetis (NYSE: ZTS) received a U.S. Department of Agriculture license for Poulvac
Zoetis (NYSE: ZTS) received a U.S. Department of Agriculture license for Poulvac Procerta HVT-ND-ILT, a new vector vaccine designed to protect chickens against Marek’s...
Palo Alto Networks to Acquire Applied Compute in $4.5 Billion AI Deal Palo Alto Networks (NASDAQ: PANW) entered into a
(NASDAQ: PANW) entered into a definitive agreement to acquire Applied Compute in an all-stock transaction valued at $4.5 billion, expanding its...
Lockheed Martin F-35C Completes First Ford-Class Carrier Launch and Recovery Tests Lockheed Martin (NYSE: LMT) said its F-35C Lightning II
Lockheed Martin (NYSE: LMT) said its F-35C Lightning II completed its first launch-and-recovery testing aboard a Gerald R. Ford-class aircraft carrier, marking a major...
Uber Eats Adds Auto Parts Delivery Through AutoParts*com Partnership Uber Technologies (NYSE: UBER) expanded its retail marketplace by partnering with
Uber Technologies (NYSE: UBER) expanded its retail marketplace by partnering with AutoParts*com, bringing automotive parts to Uber Eats for the first time. The partnership...
Abbott Starts VOYAGER Trial for Software-Guided Encantor TAVI System Abbott (NYSE: ABT) initiated the VOYAGER CE clinical trial evaluating its
Abbott (NYSE: ABT) initiated the VOYAGER CE clinical trial evaluating its investigational Encantor balloon-expandable transcatheter aortic valve implantation system for patients with symptomatic severe...
Microchip Expands RT PolarFire FPGA Portfolio With New Spaceflight Qualifications Microchip Technology (NASDAQ: MCHP) expanded its radiation-tolerant PolarFire FPGA portfolio
Microchip Technology (NASDAQ: MCHP) expanded its radiation-tolerant PolarFire FPGA portfolio with new spaceflight qualifications aimed at high-reliability aerospace and defense applications. The RT PolarFire...
Johnson & Johnson Begins Commercial Launch of OTTAVA Surgical Robot With First U.S. Installation Johnson & Johnson (NYSE: JNJ) announced
Johnson & Johnson (NYSE: JNJ) announced the first commercial installation of its OTTAVA robotic surgical system at Memorial Hermann-Texas Medical Center in Houston, marking...
Merck Partners With Isomorphic Labs to Use AI in Oncology Drug Discovery Merck (NYSE: MRK) entered a strategic research collaboration
Merck (NYSE: MRK) entered a strategic research collaboration with Isomorphic Labs to discover small-molecule drug candidates against an oncology target, combining Merck’s proprietary data...
National Bank Financial Upgrades TELUS to Outperform National Bank Financial upgraded TELUS (NYSE: TU) to Outperform from Sector Perform. TELUS
upgraded TELUS (NYSE: TU) to Outperform from Sector Perform. TELUS shares are indicated at $10.57, up 11.1%, following the upgrade. The...
Barclays Initiates Synopsys at Overweight With $640 Price Target Barclays initiated coverage of Synopsys (NASDAQ: SNPS) with an Overweight rating,
Barclays initiated coverage of Synopsys (NASDAQ: SNPS) with an Overweight rating, with analyst Saket Kalia setting a $640 price target. Synopsys shares are at...
NYSE:PANW





NYSE:BBWI

NYSE:WSM
Three Brand Name Companies Outside Of Tech That Are On The Move




S&P 500





NYSE:WMT





HKEX:9988


NASDAQ:SNPS





NYSE:MRK





NASDAQ:FUTU
NYSE:IP
